miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin

Chemoresistance is a crucial barrier to limit the therapeutic outcome of breast cancer (BC), and the mechanism underlying chemoresistance development in BC is not fully understood. In this study, we aimed to investigate the potential involvement of miR-26b-5p/serglycin (SRGN) axis in BC drug resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Qiwei, Yuan, Zuguo, Huang, Xiaoling, Huang, Yuqing, Zhang, Jie, Li, Rongguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812413/
https://www.ncbi.nlm.nih.gov/pubmed/34924500
http://dx.doi.org/10.1097/CAD.0000000000001268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812413/
https://www.ncbi.nlm.nih.gov/pubmed/34924500
http://dx.doi.org/10.1097/CAD.0000000000001268

Ejemplares similares